Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17546243 | 0.98 | CA2 (0.30) | CA2 | |
| SCHEMBL17546248 | 0.96 | CA2 (0.31) | CA2 | |
| SCHEMBL18538811 | 0.82 | — | — | |
| SCHEMBL18720367 | 0.82 | — | — | |
| SCHEMBL13557903 | 0.81 | — | — | |
| SCHEMBL25857596 | 0.79 | CES1 (0.31) | — | |
| SCHEMBL17546241 | 0.79 | — | — | |
| SCHEMBL30098479 | 0.79 | — | — | |
| SCHEMBL18538818 | 0.78 | CES1 (0.33) | — | |
| SCHEMBL18720370 | 0.78 | CES1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9273184-B1 | Synthesis of highly fluorinated amines for use in polymers and biomaterials | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2016-03-01 | — | — | US | disclosed |
| US-20120277573-A1 | ULTRASOUND-ACTIVATED NANOPARTICLES AS IMAGING AGENTS AND DRUG DELIVERY VEHICLES | CHILDREN'S HOSPITAL LOS ANGELES | 2012-11-01 | — | — | US | disclosed |
| WO-2011079317-A2 | ULTRASOUND-ACTIVATED NANOPARTICLES AS IMAGING AGENTS AND DRUG DELIVERY VEHICLES | CHILDRENS HOSPITAL LOS ANGELES (US) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120277573-A1 | ULTRASOUND-ACTIVATED NANOPARTICLES AS IMAGING AGENTS AND DRUG DELIVERY VEHICLES | SON, ABCC1, HNRNPUL1 | CA2 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.